|
Market Closed -
Australian S.E.
00:10:12 2026-11-13 EST
|
5-day change | 1st Jan Change | ||
| 0.8550 AUD | -5.52% |
|
-7.07% | +103.57% |
| Market Cap | 197M 133M 121M 112M 101M 190M 12.58B 1.34B 533M 6.72B 501M 490M 21.34B | P/E 2025 |
17.8x | P/E 2026 | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 192M 130M 118M 109M 98.44M 186M 12.27B 1.31B 520M 6.56B 488M 478M 20.81B | EV / Sales 2025 |
2.82x | EV / Sales 2026 | 2.82x |
| Free-Float |
48.94% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| BLS | Delayed | |
Deutsche Boerse AG
| PR80 | Delayed | |
|
Boerse Muenchen
| PR80 | Real-time |
Last Transcript: BLS Pharmaceuticals Limited
| 1 day | -5.52% | ||
| 1 week | -7.07% | ||
| Current month | -16.59% | ||
| 1 month | -21.20% | ||
| 3 months | -9.04% | ||
| 6 months | +1.79% | ||
| Current year | +103.57% |
| 1 week | 0.86 |  | 0.95 |
| 1 month | 0.86 | | 1.13 |
| Current year | 0.36 | | 1.3 |
| 1 year | 0.35 | | 1.3 |
| 3 years | 0.04 | | 1.3 |
| 5 years | 0.04 | | 1.3 |
| 10 years | 0.04 | | 1.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Watson
CEO | Chief Executive Officer | - | 2023-05-18 |
Guy Robertson
DFI | Director of Finance/CFO | 72 | 2016-08-31 |
Jason Hine
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peng Ho
CHM | Chairman | 67 | 2012-12-04 |
Guy Robertson
BRD | Director/Board Member | 72 | 2022-06-29 |
Sam Watson
BRD | Director/Board Member | - | 2023-05-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/23/26 | Exercice | Chief Operating Officer | 700,000 | 0.3035% | ||
| 10/23/26 | Exercice | Chief Executive Officer | 2,730,000 | 1.1836% | ||
| 5/14/26 | Buy | 5,000,000 | 0.2202% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.52% | -7.07% | +119.23% | +643.48% | 133M | |
| +1.26% | +6.61% | +40.79% | +136.32% | 1,286B | |
| +0.79% | +3.45% | +45.84% | +93.52% | 688B | |
| +0.20% | +1.28% | +26.97% | +113.70% | 521B | |
| -0.44% | +3.69% | +41.45% | +68.91% | 386B | |
| +0.55% | +0.70% | +59.02% | +44.62% | 364B | |
| -0.12% | +0.74% | +28.39% | +58.54% | 302B | |
| +0.37% | +0.37% | +3.33% | +37.27% | 287B | |
| -0.30% | +1.14% | +38.29% | +72.46% | 252B | |
| +0.08% | +0.71% | +34.44% | +124.95% | 208B | |
| Average | -0.31% | +1.16% | +43.77% | +139.38% | 429B | |
| Weighted average by Cap. | +0.54% | +3.26% | +37.70% | +96.52% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 29.28M 19.85M 17.98M 16.63M 15.01M 28.28M 1.87B 200M 79.23M 1B 74.47M 72.9M 3.17B | 73.91M 50.09M 45.4M 41.99M 37.88M 71.39M 4.72B 504M 200M 2.52B 188M 184M 8.01B |
| Net income | 4.9M 3.32M 3.01M 2.78M 2.51M 4.73M 313M 33.45M 13.26M 167M 12.47M 12.2M 531M | 15.4M 10.44M 9.46M 8.75M 7.89M 14.87M 984M 105M 41.66M 526M 39.16M 38.33M 1.67B |
| Net Debt | -6.13M -4.16M -3.77M -3.48M -3.14M -5.93M -392M -41.86M -16.6M -209M -15.6M -15.27M -665M | -4.86M -3.29M -2.98M -2.76M -2.49M -4.69M -310M -33.14M -13.14M -166M -12.35M -12.09M -526M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-13 | A$0.8550 | -5.52% | 249,502 |
| 26-11-12 | A$0.9050 | -3.21% | 172,505 |
| 26-11-11 | A$0.9350 | +1.63% | 184,104 |
| 26-11-10 | A$0.9200 | +4.55% | 158,060 |
| 26-11-09 | A$0.8800 | -4.35% | 210,691 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BLS Stock
Select your edition
All financial news and data tailored to specific country editions
